Embryo Ploidy and Ovarian Response in Gonadotropin-Releasing Hormone Antagonist Versus Progestin-Primed Ovarian Stimulation Protocols with Recombinant Luteinizing Hormone: A Within-Patient Study
OBJECTIVE: To compare embryo ploidy rates and ovarian response outcomes between gonadotropin-releasing hormone (GnRH) antagonist and progestin-primed ovarian stimulation (PPOS) cycles with recombinant luteinizing hormone (rLH) administered from stimulation onset. STUDY DESIGN: This retrospective within-patient cohort s...